Moderna COVID-19 Resources - Press Releases
Oct 3, 2025 · 8/26 – Moderna to Present New Interim Clinical Data About mRNA Vaccine Against COVID-19 (mRNA-1273) at Advisory Committee on Immunization Practices (ACIP) Meeting
Moderna data show strong immune response to updated COVID …
Sep 17, 2025 · Pfizer and BioNTech last week announced strong phase 3 clinical data for their updated COVID vaccine. Moderna said the safety profile is consistent with that of earlier …
Moderna says clinical data reinforce FDA approval of 2025-2026 …
Moderna (MRNA) announced “positive” preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19.
May 22, 2025 · Moderna 2024/2025 (KP.2) vaccine provides additional protection against COVID-related hospitalizations in a population with pre-existing immunity
Moderna COVID-19 Vaccine Summary | Vaccines & Immunizations …
Aug 28, 2024 · Overview of the COVID-19 vaccination schedule (2024–2025) A product summary to help product providers prepare orders for fall and winter virus season.
News Release - Moderna
Jun 13, 2024 · Moderna plans to present the Phase 3 clinical data for mRNA-1283 at an upcoming conference as well as submit it for publication. The Company will also engage with …
Moderna reports positive phase 3 data for mRNA seasonal flu …
Jul 2, 2025 · Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which could set the stage for the company’s …
Moderna's flu vaccine shows positive trial results, paving way for ...
Jun 30, 2025 · Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial. The positive …
A descriptive review on the real-world impact of Moderna, Inc
Areas covered: This descriptive review discusses the benefits and risks associated with marketed Moderna, Inc. mRNA-based COVID-19 vaccines, focusing on their real-world effectiveness …
Moderna updates late-stage trial data for COVID shot (MRNA)
Sep 23, 2025 · Moderna (NASDAQ: MRNA) updated data from a Phase 4 clinical trial for its redesigned COVID-19 vaccine, noting that the mRNA-based shot branded as mNEXSPIKE led …